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California, USARenal control of effective circulating volume (ECV) is key for circulatory performance. When renal sodium
excretion is inadequate, blood pressure rises and serves as a homeostatic signal to drive natriuresis to
re-establish ECV. Recognizing that hypertension involves both renal and vascular dysfunction, this report
concerns proximal tubule sodium hydrogen exchanger 3 (NHE3) regulation during acute and chronic
hypertension. NHE3 is distributed in tall microvilli (MV) in the proximal tubule, where it reabsorbs a sig-
niﬁcant fraction of the ﬁltered sodium. NHE3 redistributes, in the plane of the MV membrane, between the
MV body, where NHE3 is active, and the MV base, where NHE3 is less active. A high-salt diet and acute
hypertension both retract NHE3 to the base and reduce proximal tubule sodium reabsorption independent
of a change in abundance. The renin angiotensin system provokes NHE3 redistribution independent of
blood pressure: The angiotensin-converting enzyme (ACE) inhibitor captopril redistributes NHE3 to the
base and subsequent angiotensin II (AngII) infusion returns NHE3 to the body of the MV and restores
reabsorption. Chronic AngII infusion presents simultaneous AngII stimulation and hypertension; that is,
NHE3 remains in the body of the MV, due to the high local AngII level and inﬂammation, and exhibits a
compensatory decrease in abundance driven by the hypertension. Genetically modiﬁed mice with blunted
hypertensive responses to chronic AngII infusion (due to lack of the proximal tubule AngII receptors
interleukin-17A or interferon-g expression) exhibit reduced local AngII accumulation and inﬂammation and
larger decreases in NHE3 abundance, which improves the pressure natriuresis response and reduces the
need for elevated blood pressure to facilitate circulating volume balance.
Kidney Int Rep (2016) 1, 166–176; http://dx.doi.org/10.1016/j.ekir.2016.06.008
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NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).I n 1909, Ernest Starling published his lectures in TheFluids of the Body.1 In this monograph, Starling
outlines his thoughts on the relationship between body
ﬂuid balance, blood circulation, central venous pres-
sure, and cardiac performance. Importantly, renal
control of body ﬂuid balance is viewed as key for
circulatory and cardiac performance:1
Change in the blood ﬂow through the kidney may
bring about alterations in the ﬂow of urine quite
irrespective of the composition of the blood or of
the tissues. The occurrence of these two classes of
phenomena seems to be determined by the fact
that the kidney is a dual organ, and that while
one part of it acts, so to speak, passively inspondence: Alicia A. McDonough, Department of Cell and
biology, Keck School of Medicine of USC, 1333 San Pablo
, Los Angeles, California 90033, USA. E-mail: mcdonoug@
u
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published online 27 July 2016response to force impressed upon it from without,
another part, endowed with sensibility, reacts to
external forces in a direction which may be
opposed to these forces, but is in all cases the
appropriate one for the welfare of the whole
organism.
In 1963, Borst and Borst-de Geus2 discussed hyper-
tension in light of Starling’s theory of circulatory
homeostasis and postulated that blood pressure rises as
a homeostatic reaction to deﬁcient sodium excretion;
that is, pressure rises to reestablish sodium balance (at
the expense of persistently elevated blood pressure).2
This response, known as pressure natriuresis, has
been reviewed from various perspectives by many
investigators.3,4–7 Figure 1 shows central blood pres-
sure as a function of the ECV and cardiac output as well
as the kidneys’ regulation of sodium chloride and water
reabsorption. A kidney’s decision to excrete sodium
chloride and water is a function of mediators and
controls, both extrarenal and intrarenal, that affect theKidney International Reports (2016) 1, 166–176
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Figure 1. Central blood pressure shown as a function of the effec-
tive circulating volume and cardiac output as well as the kidneys’
regulation of sodium chloride (NaCl) and water (H2O) reabsorption,
adapted from Starling1 and Borst and Borst-De Geus.2 A kidney’s
willingness to excrete NaCl and water when blood pressure rises is
a key controller of the effective circulating volume and blood
pressure. This article examines factors, both extrarenal and intra-
renal, that reduce this willingness in the proximal tubule (and
mechanisms involved), leading to an elevation in blood pressure and
activation of pressure natriuresis mechanisms in the proximal tubule
that contribute to maintenance of effective circulating volume
homeostasis.
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storage of sodium (discussed in an accompanying
report in this series).8
Hypertension is the leading cause of stroke and
cardiovascular diseases affecting 30% of the adult
population in Western cultures.9 Blood pressure can be
elevated by vasoconstriction or by increasing ECV.
Excess sodium reabsorption raises ECV and blood
pressure, yet, according to Guyton,3 kidneys have the
capacity via pressure natriuresis to excrete enough
sodium and volume to normalize blood pressure in the
face of expanded ECV. Hypertension was classically
viewed as a failure of pressure natriuresis; however, a
recent discussion of the role of kidneys in the patho-
genesis of hypertension10 concluded that for hyper-
tension to become chronic there must be impairment of
both renal output of salt and water as well as
dysfunction of peripheral vascular tone; for example, a
failure of peripheral vasodilation due to arterial stiff-
ness. Support for the latter is provided by recent
studies illustrating a positive feedback loop wherein
arterial stiffening leads to more arterial stiffening.11Kidney International Reports (2016) 1, 166–176Although appreciating these complex interactions of
body ﬂuids, cardiac output, vascular stiffness, and
blood pressure, this report will focus on the regulation
of the renal proximal tubule NHE3 as a case-in-point
mediator of the pressure natriuresis response, specif-
ically regulation of NHE3 trafﬁcking and abundance,
our understanding of how renal dysfunction resets
NHE3 regulation to higher pressures, and strategies
that may be exploited to improve pressure natriuresis.
Proximal Tubule NHE3 Regulated by
Redistribution Within the MV
As reviewed by Palmer and Schnermann,12 the prox-
imal tubule reabsorbs two-thirds of the salt and water
ﬁltered at the glomerulus (120 ml/min) and NHE3 is the
main sodium transporter driving transcellular reab-
sorption in this region. The proximal tubule is a leaky
epithelium well built to reabsorb the w80 ml/min
ﬁltrate. As illustrated in the cross-section of the elec-
tron micrograph in Figure 2, the proximal tubule has
an apical pole covered with a tall brush border of MV
each scaffolded by an actin ﬁlament core bundled by
villin. This specialization increases the surface area for
reabsorption more than 30-fold.13 The apical MV
contain water channels as well as many different
transporters to reabsorb cations, anions, and substrates
from the ﬁltrate. Importantly, a signiﬁcant fraction of
the ﬁltered salt and water is reabsorbed via a para-
cellular route by claudins.14
Membrane transporters and channels can be regu-
lated by trafﬁcking between plasma membrane and
intracellular membranes, altered total pool size, cova-
lent modiﬁcations such as cleavage or phosphorylation,
or protein–protein interaction. Once NHE3 is localized
to the proximal tubule MV, there is scant in vivo evi-
dence for regulated trafﬁcking between MV and
intracellular pools. Rather, NHE3, localized to ordered
lipid domains (rafts) in the MV, redistribute between
the body and the base of the MV, moving in the plane
of the microvillar membranes, likely driven by the
atypical molecular motor myosin VI.15–17 This redis-
tribution from one location to another, rather than
degradation and synthesis, facilitates rapid continuous
adaptation to changing salt intake, ECV, and/or blood
pressure. Figure 2 illustrates the simple case of NHE3
regulation in the transition between normal and high-
salt diets in the absence of any change in blood pres-
sure.18 Figure 2a illustrates that this natriuresis occurs
without any change in NHE3 total abundance.
Figure 2b shows cross-sections of proximal tubules in a
model and in an electron micrograph illustrating or-
ganization of dense apical MV. NHE3 redistribution
along the proximal tubule MV is detected by colabeling
the actin bundling protein villin (red V) and NHE3167
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c
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Figure 2. Elevating salt intake from 0.4% to 4% does not change the
total abundance of proximal tubule sodium hydrogen exchanger 3
(NHE3), but redistributes NHE3 to the base of the proximal tubule
microvilli. In salt-resistant animals this occurs without an elevation
in blood pressure. (a) Immunoblots of renal cortical homogenates
from rats fed 0.4%- or 4%-salt diet.18 (b) Cross-section of proximal
tubule shown in a simple model and electron micrograph illustrating
dense apical microvilli. NHE3 redistribution along the proximal tubule
microvilli is detected by colabeling the actin bundling protein villin
(red V) and NHE3 (green circle) with specific antibodies.18 Left half
of the proximal tubule model represents the proximal tubule at a
normal-salt diet with the villin and NHE3 colocalized, yielding
microvilli stained yellow. The right half of the proximal tubule rep-
resents the proximal tubule during a high-salt diet with NHE3
retracted to the base of the microvilli exposing red V in the body of
the villi and green/yellow at the base of the microvilli. (c) Colabeling
of the proximal tubule from rats fed 0.4% sodium chloride (left half-
tubule) with both NHE3 and villin in the body of the microvilli, and
4.0% sodium chloride (right half-tubule) with NHE3 concentrated at
the base of the microvilli. (d) Myosin VI, an atypical molecular motor
implicated in the redistribution of NHE3 and sodium phosphate within
the plane of the microvilliar membrane,17,19 is located in the body
of the microvilli with a 0.4% sodium chloride diet and redistributes
to the base of the microvilli during a 4% sodium chloride diet.
MEETING REPORT AA McDonough: Hypertension and the Proximal Tubule(green circle) with speciﬁc antibodies.18 The left half of
the model represents a proximal tubule from a normal-
salt-diet-fed rat with villin and NHE3 colocalized in the
MV, yielding a yellow stain. The right half of the
proximal tubule model represents a proximal tubule
from a high-salt-diet-fed rat wherein NHE3 is retracted
to the base of the MV, exposing a red V in body of the
villi and green/yellow at the base of the MV. Figure 2c
demonstrates NHE3 in the body of the proximal tubule168MV in rats fed 0.4% sodium chloride (left half-tubule),
and to the base of the MV, in rats fed 4.0% sodium
chloride (right half-tubule). Myosin VI, an atypical
molecular motor implicated in the redistribution of
NHE3 and sodium phosphate transporter within the
plane of the microvillar membrane,17,19 also re-
distributes from the body to the base of the MV during
high-salt diet, presumably driving the NHE3
(Figure 2d). As discussed below, when NHE3 is clus-
tered at the base of the MV, its activity is predicted to
be inhibited by unfavorable pH gradients.20 Recent
studies have shown that when the excretory function
of the kidney is chronically impaired by inhibiting
nitric oxide synthase activity, the resultant renal
inﬂammation blunts the depression in sodium transport
during high-salt diet, leading to a rise in blood pres-
sure; that is, the renal dysfunction leads to salt-
sensitive hypertension.21
Evidence for a Role of Proximal Tubule in Acute
Pressure Diuresis
The classic acute pressure natriuretic protocol devel-
oped by Roman and Cowley22 and a typical response is
illustrated in Figure 3a: In inactin-anesthetized male
rats, raising mean atrial blood pressure from 87 to 130
mm Hg rapidly increases urine output more than
10-fold.23,24 Because the pressure–natriuresis response is
very large and rapid, the proximal tubule was identi-
ﬁed as a good candidate region for natriuresis—it re-
absorbs the bulk of the ﬁltered load. In the mid-1980s,
Chou and Marsh25,26 developed a video-densitometric
approach to analyze tubular ﬂow in real time and
found that acutely raising blood pressure rapidly
increased end proximal tubule ﬂow rate by 50%.
Because they also demonstrated this occurred without
appreciable changes in glomerular ﬁltration rate (GFR)
or renal blood ﬂow (due to autoregulation), they
concluded that proximal tubule sodium transport was
inhibited during acute hypertension, and that this
response contributed not only to pressure diuresis, but
also to the autoregulation of GFR and renal blood ﬂow
(mediated by increasing salt delivery to the macula
densa). This response conﬁrmed Starling’s assertions
that “the mechanisms, which determine the adaptation
of the organism to changes in the total volume of its
ﬂuid content, must come into play with every rise or
fall in the general blood pressure.”1
NHE3 Regulated by Redistribution Within the
MV During Acute Hypertension
The renal natriuretic and diuretic responses to acute or
chronic increases in blood pressure are referred to very
generally as pressure natriuresis. The responses to
acute hypertension in the proximal tubule (Figure 3)Kidney International Reports (2016) 1, 166–176
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Figure 3. Acute hypertension produced by raising total peripheral
resistance rapidly increases urine salt and volume output (pressure
natriuresis/diuresis) and redistributes the sodium hydrogen
exchanger 3 (NHE3) to the base of the proximal tubule microvilli. (a)
In inactin-anesthetized male rats, raising mean atrial blood pressure
(BP) from 87 to 130 mm Hg according to the protocol of Roman and
Cowley22 rapidly increases urine output more than 10-fold.23 (b) The
cross-section model of proximal tubule as described in Figure 2.
Colabeling of the proximal tubule from rats at baseline BP (left half-
tubule) with both NHE3 and villin in the body of microvilli, and at
elevated BP (right half-tubule) with NHE3 concentrated at the base
of the microvilli.16 (c) When angiotensin II (AngII) levels are clamped
=
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Kidney International Reports (2016) 1, 166–176are analogous to those observed during a high-salt diet
(Figure 2). The pressure–natriuretic signals, discussed
below, provoke the dynamic redistribution of apical
transporters, including NHE3 and sodium phosphate
cotransporter II (NaPiII),16 driven by molecular motors
(eg, myosin VI and IIA) and cytoskeleton-associated
proteins, to the base of the proximal tubule MV
(Figure 3b).17,19 The lipid raft-associated NHE3 remains
at the base15 and the nonraft-associated NaPiII is
endocytosed, culminating in decreased sodium trans-
port activity and increased proximal tubule ﬂow
rate.7,27,28 Recently, with Brasen et al.,20 we visualized
the hypertension-stimulated redistribution of NHE3 to
the base of the MV in vivo using 2-photon microscopy
with the pH indicator BCECF. Mathematic modeling of
this redistribution suggests that NHE3 clustering pro-
duces unfavorable pH microdomains near the bottom of
the brush border sufﬁcient to inhibit NHE3 activity.20
This conclusion helps to explain how NHE3 redistri-
bution can contribute to natriuretic responses during a
high-salt diet and acute hypertension.
The signaling that provokes the rapid decrease in
proximal tubule sodium and volume reabsorption, and
retraction of NHE3 to the base of the MV in the face
of autoregulated renal blood ﬂow and GFR appears
to involve many layers of regulation by both intrinsic
and extrinsic factors. Summarizing the ﬁndings
of multiple labs, it appears that the initial natriuretic
response is driven by rapid local generation of
20-hydroxyeicosatetraeonic acid and nitric oxide
(NO),28–30 (perhaps involving nonautoregulating
vasculature that senses the hypertension), and that the
response in the proximal tubule involves the production
of cyclic guanosinemonophosphate,31 which plays a role
in depressing sodium transport.We found that clamping
AngII levels at a nonpressor level by coinfusion of both
the ACE inhibitor captopril and AngII before the acute
hypertension protocol signiﬁcantly blunted the pres-
sure diuresis as well as the redistribution of NHE3 to the
base of the MV (Figure 3c).32,33 The decrease in AngII is
key to not only allow NHE3 redistribution to the base of
the MV, but also to sustain the response by reducing
sodium transport in AngII-sensitive regions all along the
nephron, including the distal tubule.34 Not the focus
of this review, but important to discuss in light ofby preinfusion with an angiotensin-converting enzyme inhibitor to
prevent AngII production along with a constant infusion of AngII to
maintain baseline BP, the redistribution of NHE3 to the base of the
microvilli is significantly blunted.32 The findings suggest that a drop
in local AngII may contribute to the NHE3 redistribution during acute
hypertension, and that high local AngII can blunt pressure
natriuresis.
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Figure 4. Angiotensin II (AngII) regulates sodium hydrogen exchanger
3 (NHE3) distribution in the proximal tubule microvilli. Renal cortex
examined by colabeling NHE3 (green) and villin (red) with speciﬁc
antibodies as described in Figure 1. (a) NHE3 in body of the microvilli
in an inactin-anesthetized rat at baseline. (b) Infusing captopril for
20 minutes at a dose that does not lower blood pressure (12 mg/min)
redistributes NHE3 to the base of the microvilli.39 (c) Infusing captopril
for 20 minutes followed by AngII infusion for 20 minutes (20 ng/kg/min),
at doses that do not change blood pressure, moves NHE3 from the
base to the body of the microvilli.40 (d) Coinfusing a b–arrestin-biased
AngII receptor-(AT1R) specific agonist along with captopril for
20 minutes (TRV120023) moved NHE3 to the base of the microvilli and
blocked the effects of subsequent AngII infusion.41 (e) Infusion of
AngII into rats for 14 days (400 ng/kg/min) raised the mean arterial
pressure from 120 to 160 mm Hg and decreases the total abundance of
renal cortical NHE3 by 20%, yet despite the hypertension NHE3 is
retained in the body of the microvilli.35 Images in panels a and e were
collected with the same settings, demonstrating that the ratio of NHE3
to the villin signal has decreased during AngII.
MEETING REPORT AA McDonough: Hypertension and the Proximal Tubulesignaling, is the fact that the medullary loop of Henle
also clearly participates in pressure natriuresis during
hypertension: medullary blood ﬂow, NO, and reactive
oxygen species participate as signals.35,36 A recent
report from Crowley et al.37 suggests that inﬂammatory
accumulation of interleukin-1 during hypertension ac-
tivates loop of Henle Naþ-Kþ- 2Cl- cotransporter
(NKCC2), which blunts the natriuresis and raises blood
pressure. Eliminating interleukin-1 limits the blood
pressure elevation by reducing NKCC2 sodium reab-
sorption. This study provides another example of how
injury signals contribute to hypertension by blunting
pressure natriuresis. In summary, regarding natriuretic
signaling during hypertension, there is consensus that
multiple signals have the potential to act all along the
nephron; thus, the pressure natriuresis response is the
sum of the prevailing natriuretic and antinatriuretic
inﬂuences.
Renin Angiotensin System Regulates Proximal
Tubule NHE3 Distribution and Abundance
The renin angiotensin aldosterone system is the most
powerful controller of ECV and blood pressure, as
recently reviewed by Rossier.38 AngII increases sodium
reabsorption in the proximal tubule mediated by AT1
receptors. Building on the ﬁndings of the suppression
of pressure natriuresis during the AngII clamp, we
investigated the acute effects of adding or inhibiting
AngII without changing blood pressure. Because
ACE inhibitors are among the most popular drugs
prescribed to lower blood pressure and slow the pro-
gression of renal and heart disease, it is key to under-
stand how they regulate the proximal tubule NHE3.
We addressed this issue by merging physiology and
proteomics.39 Leong et al.39 identiﬁed a dose of the ACE
inhibitor captopril that, when infused for 20 minutes
into anesthetized rats, did not change blood pressure or
GFR, but did signiﬁcantly increase urine output
(12 mg/min). With the Yip lab, they demonstrated that
this dose rapidly increased proximal tubule ﬂow rate,
evidence for ACE inhibitor suppression of proximal
tubule sodium reabsorption; Figure 4b shows that
NHE3 is retracted to the microvillar base after 20 mi-
nutes of ACE inhibitor treatment, evidence that basal
AngII is responsible, at least in part, for the location of
NHE3 within the MV at baseline.39 With the Klein lab,
Leong et al.39 applied a limited proteomic approach and
discovered that other brush border proteins that
redistribute with captopril include myosin VI, dipep-
tidyl peptidase VI, NHERF-1, ezrin, megalin, vacuolar
Hþ-ATPase, aminopeptidase N, and clathrin.
Starting with ACE inhibitor-infused rats, Riquier-
Brison et al.40 determined the effects of acute AngII
infused at a rate that did not alter blood pressure for170another 20 minutes (20 ng/kg/min) and found that the
NHE3 completely returned to the body of the MV
(AngIIþ captopril) (Figure 4c). Leong et al.39 previouslyKidney International Reports (2016) 1, 166–176
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proximal tubule ﬂow rate, providing evidence that the
NHE3 redistribution is antinatriuretic. In collaboration
with Carneiro de Morais et al.,41 we recently investi-
gated the effects of a b–arrestin-biased AT1 receptor
(AT1R) agonist (TRV120023) on proximal tubule NHE3.
Stimulating b–arrestin-biased pathways promotes
G-protein receptor internalization and desensitization
and can activate G-protein independent responses.42
Perfusing proximal tubules in vivo with the TRV com-
pound reduced bicarbonate reabsorption, a surrogate
measure of NHE3 transport, and also moved NHE3 to
the bottom of the MV.41 TRV can also prevent the ef-
fects of AngII activation: Coinfusing the TRV com-
pound with ACE inhibitors for 20 minutes blocks the
effects of subsequent 20-minute AngII infusion and
redistributes the NHE3 to the base (Figure 4d).
Experimental AngII hypertension involves infusing
AngII continuously at a dose that is initially subpressor
but eventually provokes hypertension. Using immu-
noblots of the renal cortex, we determined in rats that
after 3 days of AngII infusion (200 ng/kg/min), before
blood pressure increase, the total abundance of cortical
NHE3 increases around 50% above baseline,43 and then
by 14 days of AngII infusion (at 400 ng/kg/min), when
blood pressure is chronically elevated to 160 mm Hg,
the NHE3 abundance is depressed to 20% below base-
line.35 Figure 4e shows a proximal tubule from a 14-day
AngII-infused rat with hypertension in which NHE3 is
retained in the body of the MV.35 Images in Figure 4a
and e were collected with the same settings, demon-
strating that the ratio of NHE3 to villin signal decreased
in the MV during AngII hypertension. Overall, these
ﬁndings suggest that AngII “ﬁxes”NHE3 in theMV and
blunts redistribution, both acutely (Figure 3c) and
chronically (Figure 4e). In lieu of redistribution, a
compensatory decrease in NHE3 abundance in the MV
becomes evident as blood pressure increases. The
biphasic effects of AngII on proximal tubule reabsorp-
tion reported in rodents44 have led to the suggestion
that the decreased NHE3 abundance may be due to
high-dose AngII inhibition of NHE3, rather than hy-
pertension. However, this inhibitory effect is observed
when AngII was directly applied to tubules at doses of
(>10–7 mol/l), and not observed during systemic AngII
infusion (where the tubular AngII concentration only
reaches the nanomoles per liter range).45 Interestingly,
human proximal tubules studied in vitro only exhibit a
stimulatory transport response to AngII.46
Role of the Proximal Tubule in NHE3 Regulation
in Experimental AngII Hypertension
Blood vessels, the kidneys, and the central nervous
system are all implicated in the genesis of experimentalKidney International Reports (2016) 1, 166–176hypertension, and T-cells may provide a key link.
Animal models of chronic hypertension exhibit
increased immune inﬁltration into the vascular
adventitia and kidney.47–49 Mice and rats lacking
T-lymphocytes exhibit blunted hypertensive responses
to experimental hypertension, restored by adoptive
transfer of T-cells.50,51 Evidence suggests that the
initiating insult (whether angiotensin II infusion or
other), increases nicotinamide adenine dinucleotide
phosphate oxidase-mediated reactive oxygen species
generation, which stimulates sympathetic nervous
system activity and norepinephrine release in tissues,
which can mediate tissue T-cell activation, producing
local proinﬂammatory molecules (eg, reactive oxygen
species, neoantigens, and cytokines).52,53 In the kidney,
these processes are reported to activate local accumu-
lation of AngII, even when systemic levels of AngII are
very low.54,55 The local AngII is antinatriuretic, pro-
duces reactive oxygen species locally, and can attract
more immune cells, creating a positive feedback loop
that manifests as chronic inﬂammation and elevated
blood pressure.49,52 In rats, we determined that AngII-
infusion hypertension activates distal transporters and
channels, speciﬁcally, increasing abundance and
phosphorylation of NKCC2 and Naþ-Cl– cotransporters
and/or activating proteolytic cleavage of epithelial
sodium channels. In contrast, AngII hypertension
suppresses proximal tubule and loop of Henle trans-
porters, including NHE3, NaPiII, medullary NKCC2,
and medullary Na,K-ATPase.35 In summary, the sys-
temic AngII, inﬂammation, and intrarenal production
of AngII stimulate distal transporters and contribute to
hypertension, whereas the resultant hypertension
counteracts the effects of the AngII and depresses
proximal and loop of Henle sodium transport, facili-
tating pressure natriuresis.56
Many mouse genetic models have been subjected to
experimental AngII hypertension and several exhibit a
blunted hypertensive response to AngII infusion. We
tested the hypothesis that we could identify the locus
of the blunting of the hypertension along the nephron:
Either reduced AngII stimulation of distal transporters
or augmented pressure-natriuretic depression of
transporter abundance. This section will focus specif-
ically on the responses of NHE3. In most cases, an
augmented suppression of NHE3 abundance accompa-
nied the lower blood pressure, consistent with the
notion that local AngII locks NHE3 in the MV and
counters the responses to hypertension.
Figure 5 summarizes the measurements of renal
NHE3 abundance by immunoblot in wild type (WT)
C57Bl/6J mice and genetically modiﬁed mice in
response to 14-day AngII infusion (490 ng/kg/min).
The WT and genetically modiﬁed samples were studied171
Figure 5. In mouse genetic models that exhibit a blunted hyper-
tensive response to angiotensin II (AngII) or Nu-nitro-l-arginine
methyl ester hydrochloride (L-NAME) experimental hypertension,
sodium hydrogen exchanger 3 (NHE3) abundance is signiﬁcantly
depressed. Models treated for 14 days with AngII infusion by
osmotic minipumps include proximal tubule AT1R knockout (KO),57
mice with whole body KO of interleukin-17A,58 mice with whole
body knockout of interferon-g,58 and in mice with no kidney
angiotensin converting enzyme (ACE 10/10).60 Immunoblots of a
constant amount of renal homogenate are shown for each set of
wild-type (WT) and KO mice infused with or without AngII. The last
set shows the ACE 10/10 mice infused with L-NAME.55 These
common findings in disparate models implicate a decrease in
NHE3 abundance in the improved pressure natriuresis and blunted
hypertension. Additionally, the findings suggest that elevated
AngII, cytokines, and reactive oxygen species prevent the redis-
tribution and/or decreased abundance of NHE3 in response to
chronic sodium transport stimulation.
MEETING REPORT AA McDonough: Hypertension and the Proximal Tubuleat the same time, and results are normalized to mean
baseline results deﬁned as 1.0. In the analyses of
different sets of WT mice, we did not observe the
signiﬁcant suppression of NHE3 abundance that we
measured in rats,35 nor did we detect evidence for
AngII stimulation of NHE3; thus, the counteracting
inﬂuences of hypertension and AngII may balance at
the baseline levels in these WT mice. We have not yet
analyzed the NHE3 distribution in the MV, nor have
we determined whether NHE3 is stimulated during
short-term AngII infusion. In mice with a speciﬁc ge-
netic deletion of AT1R from the renal proximal tubule
(ATIR genetically modiﬁed mice), generated by Gurley
et al.,57 the baseline levels of NHE3 were unaltered, yet
during AngII infusion NHE3 abundance was decreased
40%, associated with a 20-mm Hg lower blood pres-
sure. In collaboration with the Harrison and Madhur
groups58 we analyzed mice lacking the ability to syn-
thesize the cytokine interleukin-17A or the cytokine
interferon-g during AngII hypertension. In both
genetically modiﬁed mouse strains, AngII decreased172abundance of NHE3 (25%-40%), myosin VI (25%), and
NaPiII (50%) associated with 20- to 25-mm Hg lower
blood pressure and improved natriuretic response to
saline infusion. A subsequent study led by the Madhur
lab59 demonstrated that the interleukin-17A strain had
little or no increase in urinary albumin or angiotensi-
nogen during AngII infusion, suggesting that
interleukin-17A may reduce intrarenal AngII. Inter-
estingly, the study also demonstrated that interleukin-
17A stimulated NHE3 expression in cultured kidney
cells mediated by serum and glucocorticoid regulated
kinase 1 phosphorylation.
With Gonzalez-Villalobos et al.60 we investigated the
sodium transporter responses in mice that were engi-
neered to express normal systemic ACE but no kidney
ACE (ACE 10/10 mice). During AngII infusion, these
mice ﬁlter and sense-infused AngII, but this AngII nor
accompanying inﬂammatory cytokines cannot stimu-
late additional local intrarenal production of AngII. In
AngII-infused ACE 10/10 mice blood pressure was
about 20-mm Hg lower, yet this was not accompanied
by a fall in NHE3 abundance. Rather, there was sup-
pression of AngII activation of distal NKCC2 and Naþ-
Cl– cotransporters (NCC).60 This same strain was also
subject to another distinct model of experimental hy-
pertension caused by inhibition of nitric oxide syn-
thase with the inhibitor Nu-nitro-l-arginine methyl
ester hydrochloride (L-NAME). In WT mice L-NAME
raises blood pressure 25 mm Hg; suppresses systemic
AngII; and through local inﬂammation, stimulates
intrarenal production of AngII. In the ACE 10/10 mice
L-NAME did not raise blood pressure, but did signif-
icantly suppress NHE3 and sodium phosphate abun-
dance by 50% and 30%, respectively.55 A third study
in the ACE 10/10 mice demonstrated that this strain is
resistant to salt-sensitive hypertension: After washout
of the L-NAME treatment, blood pressure returned to
normal in both genotypes, yet transporters remained
lower in abundance in the ACE 10/10 mice. When both
genotypes were subsequently fed a high-salt diet, the
WT mice developed a salt-sensitive rise of 20 mm Hg in
blood pressure, whereas the ACE 10/10 mice main-
tained baseline blood pressure.21 This differential
response can be attributed to the higher inﬂammation
and local production of AngII in the WT mice, and
lower NHE3 in the ACE 10/10 mice. Taken together,
the ﬁndings in these hypertension-resistant mouse
models suggest that elevated AngII, cytokines, and/or
reactive oxygen species maintain the NHE3 in the MV
and blunt the redistribution or decreased abundance of
NHE3 in response to sodium transport stimulation
along the nephron. In other words, in both AngII and
L-NAME hypertension, elevated local AngII produc-
tion put the brakes on pressure natriuretic adjustmentsKidney International Reports (2016) 1, 166–176
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pressure, and perhaps a different signaling path, is
required to decrease transporters.
Summary and Future Directions
Figure 6 provides a simpliﬁed overview of the con-
nections among sodium transport stimulation by
AngII; cytokines; reactive oxygen species; another
important activator, renal sympathetic nerve stimula-
tion; rise in effective circulating volume and blood
pressure; and suppression of proximal and loop sodium
transporters during hypertension. The results pre-
sented in this report suggest that, ultimately, the
magnitude of hypertension is determined by the
strength of the blood pressure signal(s) required to
reduce proximal nephron sodium reabsorption enough
to maintain effective circulating volume near baseline.
Our conclusion is not intended to ignore the impor-
tance of the neuro and vascular aspects of hyperten-
sion, but to focus on renal sodium handling. Based on
these ﬁndings, it is worth considering strategies to
facilitate proximal tubule natriuresis as an approach to
counteract the stimulatory inﬂuences of local AngII.
Three candidate pathways appear promising.Figure 6. Simpliﬁed overview of the connections between sodium
transport stimulation by angiotensin II (AngII); cytokines; reactive
oxygen species (ROS); and another important activator, renal sym-
pathetic nerve stimulation (RSNA); rise in effective circulating vol-
ume and blood pressure; and suppression of proximal and loop
sodium transporters during hypertension. The local activation of
proximal tubule NHE3 by intrarenal AngII, cytokines, ROS, or RSNA
can blunt pressure natriuresis responses and raise blood pressure.
Ultimately, the magnitude of hypertension is determined by the
strength of the blood pressure signal required to reduce proximal
nephron sodium reabsorption (by sodium hydrogen exchanger 3
redistribution to the base of the microvilli or depressed abundance)
to restore effective circulating volume. The signals connecting hy-
pertension to antinatriuresis are discussed in the text.
Kidney International Reports (2016) 1, 166–176AT2R-Mediated Natriuresis
AT1R and AT2R share similar afﬁnity for AngII, yet
AT2R stimulation counteracts the effects of AT1R by
increasing bradykinin and nitric oxide release, reducing
inﬂammation, promoting vasodilation and natri-
uresis.61,62 AngIII is the likely ligand for AT2R.63 Hill-
iard et al.62,64 showed that direct stimulation of AT2R
with the selective agonist C21 increases natriuresis and
diuresis without changes in GFR or RBF, evidence for
tubular actions. The Carey group conﬁrmed these ﬁnd-
ings in volume expanded female rats, also showing C21
may move NHE3 to the base of the MV, and that the
natriuresis was dependent on nitric oxide and bradyki-
nin.65 Hilliard et al.64 demonstrated that the lower blood
pressure and more sensitive pressure natriuresis
observed in WT female rodents is associated with 4-fold
higher AT2R mRNA; and that this sex advantage
disappears with age and in global AT2R KO mice.66 This
fast-growing area full of therapeutic potential61,62 has a
large gap in knowledge about how AT2R signaling
affects sodium transporters/channels and intrarenal
renin angiotensin system in male and female humans.
Glucagon-Like Peptide–1-Mediated Natriuresis
Glucagon like peptide-1 (GLP-1) is an incretin hormone
constantly secreted from the intestine at low basal
levels in the fasted state. Plasma concentrations rise
rapidly after nutrient ingestion. Upon release, GLP-1
exerts insulinotropic effects via a G protein-coupled
receptor, stimulation of adenylyl cyclase, and cyclic
adenosine monophosphate generation. Although pri-
marily involved in glucose homeostasis, GLP-1 can
induce diuresis and natriuresis when administered in
pharmacologic doses in humans and rodents. Carraro-
Lacroix et al.67 and Crajoinas et al.68 deﬁned the
chronic effects of stimulation of the incretin receptor
GLP-1 in kidney and discovered that GLP-1 has
diuretic and natriuretic effects mediated by changes in
both renal hemodynamic parameters and by down-
regulation of proximal tubule NHE3 activity.68
Recently, Farah et al.69 demonstrated that endogenous
baseline GLP-1 plays a signiﬁcant role in regulating
renal function. They blocked the GLP-1 receptor with
the antagonist exendin-9 in overnight-fasted anes-
thetized rats. Exendin–9-infused (30 minutes) rats
exhibited reduced GFR, lithium clearance, urinary
volume ﬂow, and sodium excretion compared with
vehicle-infused controls. NHE3 phosphorylation at a
site associated with retraction to the base was also
increased. Collectively, these results provide novel
evidence that GLP-1 is a physiologically relevant
natriuretic factor that contributes to sodium balance, in
part, via tonic modulation of sodium transport activity
in the proximal tubule.173
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The sodium-glucose-cotransporter inhibitors used to
treat diabetes directly target the proximal tubule,
provoke natriuresis and diuresis, and may lower blood
pressure.70 Pessoa et al.71 recently reported that NHE3
activity is stimulated by luminal glucose, and that
NHE3 colocalizes and may functionally interact with
sodium-glucose-cotransporter 2 in the proximal tubule.
Thus, it is possible that sodium-glucose-cotransporter 2
inhibition may inhibit NHE3 transport activity.
Dopamine Receptor-Mediated Natriuresis
The intrarenal dopaminergic system is an important
determinant of the blood pressure set point: Reduced
dopamine signaling is associated with hypertension.72–74
There are 5 dopamine receptors in the kidney: D1R and
D5R (D1likeR) physically interact and their activation
inhibits NHE3 and Na,K-ATPase75; thus, counteracting
the effects of AngII via AT1R.63 D1likeR activation in-
creases salt and water excretion mediated by inhibition of
proximal tubule NHE3, sodium phosphate, and
Na,K-ATPase as well as loop of Henle NKCC2, the prox-
imal sites that can elicit pressure natriuresis.76 Addition-
ally, dopamine receptor activation is known to antagonize
AT1R signaling, reduce intrarenal renin angiotensin
system components,63,76,77 and stimulate AT2R
signaling.78 Numerous labs have provided evidence for
functional complexes between Ang AT1R and DA D1R79
inwhich activation of one attenuates the expression of the
other. Likewise, AT2Rs may oppose AT1Rs by protein–
protein interaction.63 Thus, effects of dopamine deﬁ-
ciency include AT1R activation and vice versa.
Determining how the pressor and natriuretic arms of
the renin angiotensin system, in parallel with the
interacting dopaminergic system, regulate transporters
and channels may ﬁll important gaps in understanding
the sexual dimorphism of blood pressure and provide
new and sex-speciﬁc therapeutic approaches to treat
resistant hypertension.
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